Concepedia

Theresa O’Malley

TO

Statistics

Publications

15

Citations

944

H-Index

14

Active since

1970

Affiliations

Infectious Disease Research Institute(Current)

Texas A&M University

Eli Lilly (United States)

Colorado State University

Theresa O’Malley is an author at Infectious Disease Research Institute specializing in drug discovery, mycobacterium tuberculosis infection, and pharmacology.

Publications per year

1970–2020

15

Publications

15

Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosis

Thomas R. Ioerger, Theresa O’Malley, Reiling Liao et al. · PLoS ONE · 2013 · 251 citations · Full text

, , +14

Validation of the Essential ClpP Protease in Mycobacterium tuberculosis as a Novel Drug Target

Juliane Ollinger, Theresa O’Malley, Edward A. Kesicki et al. · Journal of Bacteriology · 2011 · 133 citations · Full text

, , +14

Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase

Andrés Palencia, Xianfeng Li, Wei Bu et al. · Antimicrobial Agents and Chemotherapy · 2016 · 121 citations · Full text

, , +16

Improved Phenoxyalkylbenzimidazoles with Activity against <i>Mycobacterium tuberculosis</i> Appear to Target QcrB

N. Susantha Chandrasekera, Bryan J. Berube, Gauri Shetye et al. · ACS Infectious Diseases · 2017 · 68 citations · Full text

, , +14

Imidazopyridine Compounds Inhibit Mycobacterial Growth by Depleting ATP Levels

Theresa O’Malley, Torey Alling, Julie V. Early et al. · Antimicrobial Agents and Chemotherapy · 2018 · 54 citations · Full text

, , +15

1–5 of 15